¶¶Òõ´«Ã½ÔÚÏß

China has set a target for its nuclear technology application industry to generate annual direct economic output value of CNY400 billion (USD55.7 billion) by 2026.

The 24 months since commercial production of the medical isotope began at the Candu unit have seen Bruce Power and its partners expand production capabilities to match growing global demand.

A 50% increase in molybdenum-99 and 22% more iodine-131 will be produced by adding an extra shift and increasing the hours of irradiation at the RA-3 reactor, Argentina's National Atomic ¶¶Òõ´«Ã½ÔÚÏß Commission (CNEA) has said.

Romania's nuclear power plant operator Nuclearelectrica and France's Framatome are aiming to launch a full-scale commercial irradiation service for medical isotopes in 2028.

TerraPower Isotopes announced it is producing actinium-225 at commercial scale. The medical radioisotope is being produced from material recovered from a legacy uranium-233 inventory at a US national laboratory.

Kronos Advanced Technologies Inc and Yasheng Group have announced a strategic collaboration to develop and file a patent for a small nuclear battery powered by the decay of nickel-63. The partnership aims to address critical energy storage needs across various sectors, including remote sensing, space exploration, medical devices and military applications.

Canadian Nuclear Laboratories has received shipments of disused radium-226 sources from the Thailand Institute of Nuclear Technology, which will be recycled to produce actinium-225 to be used in targeted radiotherapy.

California-based Infinity Power says it has successfully developed a very powerful and long-lasting nuclear battery that uses electrochemical energy conversion.

A second isotope production line is being installed at Bruce 7 to double its production capacity to meet forecast increases in demand. Bruce Power and Saugeen Ojibway Nation have also announced an expansion of their partnership for the production of and marketing of medical radioisotopes.

Leaders from the US Department of ¶¶Òõ´«Ã½ÔÚÏß’s National Nuclear Security Administration and the European Commission have highlighted the need to strengthen security of radioactive sources in open civilian facilities such as hospitals, research laboratories, and industrial facilities to prevent the use of these materials in acts of terrorism.

Days after beginning trading on the New York Stock Exchange, US-based fast fission plant developer Oklo Inc has announced it is forming a strategic partnership with Atomic Alchemy to produce radioisotopes from Oklo's recycling process and through fast reactor production of isotopes.

Argentina's National Atomic ¶¶Òõ´«Ã½ÔÚÏß Commission and nuclear construction specialists INVAP have held a workshop focused on the design of the facility which will form part of the complex alongside the new RA-10 multipurpose reactor.